Please login to the form below
Rethinking Electronic Medical Records
EMR systems are far from perfect. Clinician and PhD candidate Dr. Pao takes us through his perspective on the system and how he aims to lead the way by solving the challenges when adopting this technology in a clinical setting.
Imagine a world where medical records are never lost, doctors and hospitals are more efficient, and no matter where you are, your physician can access your notes at the click of a button. That’s the attractive promise of the electronic medical record (EMR).
Hospitals across the western world are buying into EMR systems. The prestigious Great Ormond Street Hospital in London has just embarked on a £50 million project to digitalise its paper records. Walk through the hospital corridors and you will spot banners with slogans such as ‘Future Proof’ and ‘We can do this,’ designed to assure doctors of the benefits of the new technology.
In New York City, Mount Sinai also began implementing an EMR system as early as 2005 in a bid to go paper-free and to ensure many of the hospitals systems are connected through one technology provider. Despite this, in 2019, the technology is yet to be fully applied.
The hospital says this is to minimise disruption; however, mounting evidence suggests the most popular EMR systems are not fit for purpose.
With one recent report revealing 95% of clinicians associate EMR usability with burnout, it’s clear the technology is not living up to the hype. A lack of user-friendly interfaces coupled with little capability for interoperability is frustrating physicians and impacting their relationships with patients.
One doctor is trying to change this. Dr Dave Pao is both a clinician and a design PhD candidate at the Royal College of Art, London. He has more than 20 years’ experience working as a doctor in sexual health and HIV and he has experienced the negative impact of EMRs first hand. Now, he is championing the design of EMR through visual provotyping, which aims to solve some of the clinician’s biggest challenges when using the technology in a clinical setting.
DOWNLOAD THE FULL ARTICLE HERE
Company Details
Blue Latitude Health
Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom
Latest content on this profile
- Three strategies for managing loss of exclusivity successfully
- Consultant, Claire Taylor explains why you should be strategically planning your LOE strategy years in advance.
Blue Latitude Health
- What does the future hold for Medical Affairs?
- Lori Lush, Head of Fishawack Medical, reveals why she’s driven to tell impactful scientific stories, the benefits of cross-functional collaboration, and the trends she predicts for the next five years.
Blue Latitude Health
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the life sciences industry can do to rebuild trust.
Blue Latitude Health
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and Senior Consultant Craig Moore explore the benefits of using real-world evidence and the common pitfalls life science companies should avoid.
Blue Latitude Health
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of this lost time for patients?
Blue Latitude Health
- Unpacking rare diseases in the first edition of Delta magazine
- Fishawack Health launches Delta magazine with a deep dive into rare disease commercialization
Blue Latitude Health
